Is there selection in favour of heterozygotes in families with merosin-deficient congenital muscular dystrophy?

被引:3
作者
D'Alessandro, M [1 ]
Naom, I [1 ]
Ferlini, A [1 ]
Sewry, C [1 ]
Dubowitz, V [1 ]
Muntoni, F [1 ]
机构
[1] Hammersmith Hosp, Imperial Coll, Sch Med, Div Paediat,Neuromuscular Unit, London W12 0NN, England
关键词
D O I
10.1007/s004390051106
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Merosin-deficient congenital muscular dystrophy is an autosomal recessive neuromuscular disorder caused by partial or total absence of laminin-2 (merosin) in the skeletal muscle. Affected children have severe weakness. hypotonia at birth, high creatine kinase (CK) levels (more than 10 times normal) and are not able to walk or stand unsupported. Linkage and mutation analysis demonstrated that the gene encoding for the laminin-alpha 2 chain, mapped on chromosome 6q22-23, is invariably responsible for this form of congenital muscular dystrophy. We investigated the pattern of inheritance of the haplotypes associated with the mutated allele in 29 informative merosin-deficient families, using tightly linked informative polymorphic microsatellite markers. This allowed us to identify heterozygous individuals from normal homozygotes, who are clinically, pathologically and biochemically indistinguishable. By linkage analysis, we found a statistically significant increase in the number of heterozygous individuals carrying either the paternal or the maternal haplotypes associated with the mutated allele. This could suggest a selection in favour of the alleles carrying mutations at the laminin alpha 2-chain locus.
引用
收藏
页码:308 / 313
页数:6
相关论文
共 21 条
[1]  
EMERY AEH, 1996, PRINCIPLES PRACTICE, P121
[2]  
FLEMING AF, 1996, LANCET, V47, P1634
[3]   PCR based mutation screening of the laminin α2 chain gene (LAMA2):: application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy [J].
Guicheney, P ;
Vignier, N ;
Zhang, X ;
He, Y ;
Cruaud, C ;
Frey, V ;
Helbling-Leclerc, A ;
Richard, P ;
Estournet, B ;
Merlini, L ;
Topaloglu, H ;
Mora, M ;
Harpey, JP ;
Haenggeli, CA ;
Barois, A ;
Hainque, B ;
Schwartz, K ;
Tome, FMS ;
Fardeau, M ;
Tryggvason, K .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (03) :211-217
[4]  
HelblingLeclerc A, 1995, CR ACAD SCI III-VIE, V318, P1245
[5]   LOCALIZATION OF MEROSIN-NEGATIVE CONGENITAL MUSCULAR-DYSTROPHY TO CHROMOSOME 6Q2 BY HOMOZYGOSITY MAPPING [J].
HILLAIRE, D ;
LECLERC, A ;
FAURE, S ;
TOPALOGLU, H ;
CHIANNILKULCHAI, N ;
GUICHENEY, P ;
GRINAS, L ;
LEGOS, P ;
PHILPOT, J ;
EVANGELISTA, T ;
ROUTON, MC ;
MAYER, M ;
PELLISSIER, JF ;
ESTOURNET, B ;
BAROIS, A ;
HENTATI, F ;
FEINGOLD, N ;
BECKMANN, JS ;
DUBOWITZ, V ;
TOME, FMS ;
FARDEAU, M .
HUMAN MOLECULAR GENETICS, 1994, 3 (09) :1657-1661
[6]   Genetic epidemiology of congenital muscular dystrophy in a sample from north-east Italy [J].
Mostacciuolo, ML ;
Miorin, M ;
Martinello, F ;
Angelini, C ;
Perini, P ;
Trevisan, CP .
HUMAN GENETICS, 1996, 97 (03) :277-279
[7]  
MULLENBACH R, 1989, TRENDS GENET, V5, P391
[8]  
Naom I, 1996, AM J HUM GENET, V59, P226
[9]   Refinement of the laminin alpha 2 chain locus to human chromosome 6q2 in severe and mild merosin deficient congenital muscular dystrophy [J].
Naom, IS ;
DAlessandro, M ;
Topaloglu, H ;
Sewry, C ;
Ferlini, A ;
HelblingLeclerc, A ;
Guicheney, P ;
Weissenbach, J ;
Schwartz, K ;
Bushby, K ;
Philpot, J ;
Dubowitz, V ;
Muntoni, F .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (02) :99-104
[10]   Laminin α2 muscular dystrophy -: Genotype/phenotype studies of 22 patients [J].
Pegoraro, E ;
Marks, H ;
Garcia, CA ;
Crawford, T ;
Mancias, P ;
Connolly, AM ;
Fanin, M ;
Martinello, F ;
Trevisan, CP ;
Angelini, C ;
Stella, A ;
Scavina, M ;
Munk, RL ;
Servidei, S ;
Bönnemann, CC ;
Bertorini, T ;
Acsadi, G ;
Thompson, CE ;
Gagnon, D ;
Hoganson, G ;
Carver, V ;
Zimmerman, RA ;
Hoffman, EP .
NEUROLOGY, 1998, 51 (01) :101-110